Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
126675841	12667584	1	I	20160712	20160801	20160819	20160819	EXP		PHHY2016DE107403	NOVARTIS		35.00	YR		F	Y	74.00000	KG	20160819		MD	DE	DE

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	DECHAL	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
126675841	12667584	1	PS	TASIGNA	NILOTINIB	1	Oral	2 DF OF 150 MG, BID	Y	22068	2	DF	CAPSULE	BID
126675841	12667584	2	SS	TASIGNA	NILOTINIB	1	Oral	1 DF OF 150 MG, BID	Y	22068	1	DF	CAPSULE	BID
126675841	12667584	3	C	PANTOPRAZOLE	PANTOPRAZOLE SODIUM	1	Oral	20 MG, QD		0	20	MG		QD

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
126675841	12667584	1	Chronic myeloid leukaemia
126675841	12667584	3	Gastric disorder

Outcome of event

Event ID	CASEID	OUTC COD
126675841	12667584	HO

Reactions reported

Event ID	CASEID	PT
126675841	12667584	Dyspnoea
126675841	12667584	Headache
126675841	12667584	Pleural effusion

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT	DUR	DUR COD
126675841	12667584	1	20150505		0
126675841	12667584	3	20150825		0